Why metformin matters beyond diabetes: New target could reshape aging and cancer research

Scientists at Université de Montréal have figured out how metformin—a common drug that's used to treat type-2 diabetes and that may cut the risk of developing cancer and even help humans and other mammals live longer—actually works.